Aarti Drugs Ltd reports Q2 FY27 consolidated revenue of ₹826.24 crore and net profit of ₹82.77 crore
- Revenue rose 26.6% year on year and 17.6% sequentially; net profit increased 64.9% year on year and 65.1% sequentially.
- Consolidated operating EBITDA margin was approximately 16.7%; no exceptional item was reported.
- Auditors issued unmodified opinions; one foreign subsidiary’s results were management-certified and unaudited, without modification to the opinion.